Adjusting working conditions and evaluating the risk of infection during the COVID-19 pandemic in different workplace settings in Germany: a study protocol for an explorative modular mixed methods approach.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
18 11 2020
Historique:
entrez: 19 11 2020
pubmed: 20 11 2020
medline: 15 12 2020
Statut: epublish

Résumé

Currently, many countries, affected by the COVID-19 pandemic, discuss how the 'lockdown-restrictions' could be lifted to restart the economy and public life after the first wave of the COVID-19 disease has subsided. This study protocol describes an approach designed to provide an in-depth understanding of how companies and their employees in Germany deal with their working conditions during the COVID-19 pandemic. We are also interested in how and why the risk of infection with SARS-CoV-2 could vary across different professional activities, company sites and regions with different epidemiological activity or infection control measures in Germany. We expect the results of this study to contribute to the development of working conditions protecting the health of employees during and beyond the COVID-19 pandemic. An explorative multimodal mixed methods approach will be applied. The approval of the study design was received in June 2020 from the responsible local ethical committee of the Medical Faculty, University of Tübingen and University Hospital Tübingen (No. 423/2020BO). The results will be presented at national and international conferences and published in peer-reviewed journals.

Identifiants

pubmed: 33208339
pii: bmjopen-2020-043908
doi: 10.1136/bmjopen-2020-043908
pmc: PMC7677339
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e043908

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Health Serv Res Policy. 2008 Apr;13(2):92-8
pubmed: 18416914
J Am Acad Dermatol. 2020 Apr;82(4):1034
pubmed: 32081700
BMJ. 1995 Jul 22;311(6999):251-3
pubmed: 7627048
Lancet Respir Med. 2020 Apr;8(4):e19
pubmed: 32105633
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
J Bus Res. 2020 Sep;118:253-261
pubmed: 32834211
Lancet Public Health. 2020 Apr;5(4):e193
pubmed: 32119831
J Transp Health. 2020 Sep;18:100877
pubmed: 32501420
Arch Bone Jt Surg. 2020 Apr;8(Suppl1):242-246
pubmed: 32607395
Saf Sci. 2020 Sep;129:104806
pubmed: 32382213
Am J Ind Med. 2020 Aug;63(8):659-662
pubmed: 32452556
JRSM Short Rep. 2013 May 07;4(6):2042533313479197
pubmed: 23885291
Z Evid Fortbild Qual Gesundhwes. 2018 May;133:9-23
pubmed: 29605568
BMJ Glob Health. 2020 Jul;5(7):
pubmed: 32641292
Qual Health Res. 2016 Nov;26(13):1753-1760
pubmed: 26613970
Malays Fam Physician. 2020 Mar 18;15(1):2-5
pubmed: 32284798

Auteurs

Esther Rind (E)

Institute of Occupational and Social Medicine and Health Services Research, University Hospital Tübingen, University of Tübingen, Tübingen, Germany esther.rind@med.uni-tuebingen.de.

Klaus Kimpel (K)

Medical Services, Robert Bosch GmbH, Stuttgart, Germany.

Christine Preiser (C)

Institute of Occupational and Social Medicine and Health Services Research, University Hospital Tübingen, University of Tübingen, Tübingen, Germany.
Coordination Centre, Core Facility for Health Services Research, University of Tübingen, Faculty of Medicine, Tübingen, Germany.

Falko Papenfuss (F)

Medical Services, Robert Bosch GmbH, Stuttgart, Germany.

Anke Wagner (A)

Institute of Occupational and Social Medicine and Health Services Research, University Hospital Tübingen, University of Tübingen, Tübingen, Germany.

Karina Alsyte (K)

Medical Services, Robert Bosch GmbH, Stuttgart, Germany.

Achim Siegel (A)

Institute of Occupational and Social Medicine and Health Services Research, University Hospital Tübingen, University of Tübingen, Tübingen, Germany.

Antje Klink (A)

Medical Services, Robert Bosch GmbH, Stuttgart, Germany.

Benjamin Steinhilber (B)

Institute of Occupational and Social Medicine and Health Services Research, University Hospital Tübingen, University of Tübingen, Tübingen, Germany.

Johanna Kauderer (J)

Medical Services, Robert Bosch GmbH, Stuttgart, Germany.

Monika A Rieger (MA)

Institute of Occupational and Social Medicine and Health Services Research, University Hospital Tübingen, University of Tübingen, Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH